Journal of Vaccine Research 2024, Vol.14, No.6, 316-323 http://medscipublisher.com/index.php/jvr 322 Geisen U., Berner D., Tran F., Sümbül M., Vullriede L., Ciripoi M., Reid H., Schaffarzyk A., Longardt A., Franzenburg J., Hoff P., Schirmer J., Zeuner R., Friedrichs A., Steinbach A., Knies C., Markewitz R., Morrison P., Gerdes S., Schreiber S., and Hoyer B., 2021, Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort, Annals of the Rheumatic Diseases, 80: 1306-1311. https://doi.org/10.1136/annrheumdis-2021-220272 Gote V., Bolla P., Kommineni N., Butreddy A., Nukala P., Palakurthi S., and Khan W., 2023, A comprehensive review of mRNA vaccines, International Journal of Molecular Sciences, 24(3): 2700. https://doi.org/10.3390/ijms24032700 Iavarone C., O’Hagan D., Yu D., Delahaye N., and Ulmer J., 2017, Mechanism of action of mRNA-based vaccines, Expert Review of Vaccines, 16(9): 871-881. https://doi.org/10.1080/14760584.2017.1355245 Ismail S., Ahmad S., and Azam S., 2020, Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens, European Journal of Pharmaceutical Sciences, 155: 105258. https://doi.org/10.1016/j.ejps.2020.105258 Jackson N., Kester K., Casimiro D., Gurunathan S., and Derosa F., 2020, The promise of mRNA vaccines: a biotech and industrial perspective, NPJ Vaccines, 5: 11. https://doi.org/10.1038/s41541-020-0159-8 Kim J., Eygeris Y., Gupta M., and Sahay G., 2021, Self-assembled mRNA vaccines, Advanced Drug Delivery Reviews, 170: 83-112. https://doi.org/10.1016/j.addr.2020.12.014 Kis Z., 2022, Stability modelling of mRNA vaccine quality based on temperature monitoring throughout the distribution chain, Pharmaceutics, 14(2): 430. https://doi.org/10.3390/pharmaceutics14020430 Kowalczyk A., Doener F., Zanzinger K., Noth J., Baumhof P., Fotin‐Mleczek M., and Heidenreich R., 2016, Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity, Vaccine, 34(33): 3882-3893. https://doi.org/10.1016/j.vaccine.2016.05.046 Liang Y., Huang L., and Liu T., 2021, Development and delivery systems of mRNA vaccines, Frontiers in Bioengineering and Biotechnology, 9: 718753. https://doi.org/10.3389/fbioe.2021.718753 Maruggi G., Zhang C., Li J., Ulmer J., and Yu D., 2019, mRNA as a transformative technology for vaccine development to control infectious diseases, Molecular Therapy, 27(4): 757-772. https://doi.org/10.1016/j.ymthe.2019.01.020 Mbatha L., Akinyelu J., Maiyo F., and Kudanga T., 2023, Future prospects in mRNA vaccine development, Biomedical Materials, 18(5): 052005. https://doi.org/10.1088/1748-605X/aceceb Notarte K., Ver A., Velasco J., Pastrana A., Catahay J., Salvagno G., Yap E., Martínez-Sobrido L., Torrelles J., Lippi G., and Henry B., 2021, Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review, Critical Reviews in Clinical Laboratory Sciences, 59(7): 1-18. https://doi.org/10.1080/10408363.2022.2038539 Pardi N., Hogan M., and Weissman D., 2020, Recent advances in mRNA vaccine technology, Current Opinion in Immunology, 65: 14-20. https://doi.org/10.1016/j.coi.2020.01.008 Pardi N., Hogan M., Porter F., and Weissman D., 2018, mRNA vaccines — a new era in vaccinology, Nature Reviews Drug Discovery, 17: 261-279. https://doi.org/10.1038/nrd.2017.243 Rosa S., Prazeres D., Azevedo A., and Marques M., 2021, mRNA vaccines manufacturing: challenges and bottlenecks, Vaccine, 39: 2190-2200. https://doi.org/10.1016/j.vaccine.2021.03.038 Rzymski P., Szuster‐Ciesielska A., Dzieciątkowski T., Gwenzi W., and Fal A., 2023, mRNA vaccines: the future of prevention of viral infections?, Journal of Medical Virology, 95(3): e28572. https://doi.org/10.1002/jmv.28572 Shou C.J., and Cai X.P., 2024, Analysis of animal vaccine classification and current status, Journal of Vaccine Research, 14(1): 10-16. https://doi.org/10.5376/jvr.2024.14.0002 Son S., and Lee K., 2022, Development of mRNA vaccines/therapeutics and their delivery system, Molecules and Cells, 46(1): 41-47. https://doi.org/10.14348/molcells.2023.2165 PMid: 36637795 Sun H., Zhang Y., Wang G., Yang W., and Xu Y., 2023, mRNA-based therapeutics in cancer treatment, Pharmaceutics, 15(2): 622. https://doi.org/10.3390/pharmaceutics15020622 Uddin M., and Roni M., 2021, Challenges of storage and stability of mRNA-based COVID-19 vaccines, Vaccines, 9(9): 1033. https://doi.org/10.3390/vaccines9091033 Xiao Y., Tang Z., Huang X., Chen W., Zhou J., Liu H., Liu C., Kong N., and Tao W., 2022, Emerging mRNA technologies: delivery strategies and biomedical applications, Chemical Society Reviews, 51: 3828-3845. https://doi.org/10.1039/d1cs00617g Xu S., Yang K., Li R., and Zhang L., 2020, mRNA vaccine era—mechanisms, drug platform and clinical prospection, International Journal of Molecular Sciences, 21(18): 6582. https://doi.org/10.3390/ijms21186582
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==